Tumefactive: A Rare First presentation of Multiple Sclerosis [PDF]
Disease and Diagnosis, 2018 Tumefactive demyelinating lesions are a rare presentation of multiple sclerosis (MS). Diagnosis of tumefactive is commonly carried out using magnetic resonance image (MRI). Tumefactive diagnosis is difficult because of may similar to the clinical and MRI
Athena Sharifi Razavi +3 more
doaj +1 more source
When tumefactive demyelination is truly a tumor: case report of a radiographic misdiagnosis
CNS Oncology, 2021 Oligodendrogliomas are slow-growing tumors that account for 15–20% of gliomas. This case report describes the case of an adult male patient diagnosed initially with tumefactive demyelination and multiple sclerosis, which was subsequently found to be a ...
Breanna Taylor +2 more
doaj +1 more source
Neurology International, 2021 Distinguishing between tumefactive demyelinating lesions (TDLs) and brain tumors in multiple sclerosis (MS) can be challenging. A progressive course is highly common with brain tumors in MS and no single neuroimaging technique is foolproof when ...
Chantal Kahovec +2 more
doaj +1 more source
Longitudinal Brain Atrophy Patterns in Early MOG-Antibody Associated Disease and Relapsing Multiple Sclerosis. [PDF]
Eur J NeurolABSTRACT Background Myelin oligodendrocyte glycoprotein antibody‐associated disease can manifest as a relapsing or monophasic condition. Although several MRI studies have shown evident gray and white matter atrophy compared to healthy controls, little is known about regional brain volume dynamics in myelin oligodendrocyte glycoprotein antibody ...
Ladopoulos T +10 more
europepmc +2 more sources
Frontiers in Immunology, 2022 ObjectiveTo track the clinical outcomes in patients who initially presented with tumefactive demyelinating lesions (TDLs), we summarized the clinical characteristics of various etiologies, and identified possible relapse risk factors for TDLs ...
Xinnan Li +9 more
doaj +1 more source
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
Case Reports in Radiology, 2012 Tumefactive demyelinating lesion is defined as large solitary demyelinating lesion with imaging characteristics mimicking neoplasm. These atypical features include size more than 2 cm, mass effect, edema, and/or ring enhancement.
Hossein Kalanie +3 more
doaj +1 more source
Baló’s concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures [PDF]
, 2018 Background: Baló’s concentric sclerosis (BCS) is a rare inflammatory demyelinating disorder of the central nervous system characterised by concentric layers of demyelination.
Behrens, J. R. +6 more
core +3 more sources
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series. [PDF]
, 2016 Alemtuzumab is an anti-CD52 monoclonal antibody recently licensed for use in relapsing-remitting multiple sclerosis. Here, we report our experience of its use in neuromyelitis optica (NMO) spectrum disorders.
Azzopardi, L +4 more
core +1 more source
Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
Frontiers in Neurology, 2022 Tumefactive demyelinating lesions (TDL) represent a diagnostic dilemma for clinicians, and in rare atypical cases a collaboration of a neuroradiologist, a neurologist, and a neuropathologist is warranted for accurate diagnosis.
Aigli G. Vakrakou +5 more
doaj +1 more source
Acute hemichorea as unusual first multiple sclerosis presentation [PDF]
, 2016 Patient 1 was a 39-year-old woman with an unremarkable medical history who developed acute involuntary right arm and leg movements. Neurologic examination revealed moderate dysarthria and subcontinuous, choreic movements in her right limbs, prevailing in
Cavallieri, Francesco +6 more
core +1 more source